India markets open in 2 hours 22 minutes
  • BSE SENSEX

    48,677.55
    +424.04 (+0.88%)
     
  • Nifty 50

    14,617.85
    +121.35 (+0.84%)
     
  • Dow

    34,230.34
    +97.31 (+0.29%)
     
  • Nasdaq

    13,582.42
    -51.08 (-0.37%)
     
  • BTC-INR

    4,193,530.00
    +141,126.25 (+3.48%)
     
  • CMC Crypto 200

    1,458.70
    +53.40 (+3.80%)
     
  • Hang Seng

    28,417.98
    0.00 (0.00%)
     
  • Nikkei

    29,302.59
    +489.96 (+1.70%)
     
  • EUR/INR

    88.6343
    +0.0040 (+0.00%)
     
  • GBP/INR

    102.6364
    -0.0033 (-0.00%)
     
  • AED/INR

    20.0510
    0.0000 (0.00%)
     
  • INR/JPY

    1.4771
    +0.0007 (+0.05%)
     
  • SGD/INR

    55.2680
    -0.0040 (-0.01%)
     

2021 Epidemiology Forecast for the Global Herpes Market to 2035 - ResearchAndMarkets.com

·2-min read

The "Global Herpes Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

The research report provides Herpes epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Herpes patients, history of the disease at the population level (Herpes prevalence, Herpes incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Herpes patient flow: Herpes prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Herpes patients by age group, gender

  • Forecast: Herpes epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Herpes market sizing, assessing market potential, and developing drug forecast models

  • Identify Herpes patients segments through age groups, gender, and disease sub-types

  • Develop Herpes population-based health management frameworks

  • Evaluate Herpes market opportunities, identify target patient population

  • Align marketing decisions with the Herpes target population

  • Communicate leadership and health authorities about your Herpes target patient population

Key Topics Covered:

1. Research Methodology

2. Herpes Patients Definition

3. US Herpes Epidemiology and Patient Flow

4. Germany Herpes Epidemiology and Patient Flow

5. France Herpes Epidemiology and Patient Flow

6. Italy Herpes Epidemiology and Patient Flow

7. Spain Herpes Epidemiology and Patient Flow

8. UK Herpes Epidemiology and Patient Flow

9. Europe Herpes Epidemiology and Patient Flow

10. Japan Herpes Epidemiology and Patient Flow

11. Global Herpes Epidemiology and Patient Flow

12. Sources

For more information about this report visit https://www.researchandmarkets.com/r/7f3bg1

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504006091/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900